Blinding and Its Quality in Clinical Trials Conducted on Patients with Breast Cancer: A Systematic Review

BACKGROUND: Blinding is one of the critical criteria of clinical trials that prevents probable bias. Judgment regarding results of an intervention significantly depends on the quality of such studies, one of which is blinding. This study aimed to investigate blinding and its quality in clinical tria...

Descripción completa

Detalles Bibliográficos
Autores principales: Matourypour, Pegah, Ghorbani, Azam, Mahmoudi, Mokhtar, Binaei, Niloufar, Manesh, Hadi Jafary, Nayeri, Nahid Dehghan, Bagheri, Imane
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865247/
https://www.ncbi.nlm.nih.gov/pubmed/35280192
http://dx.doi.org/10.4103/ijnmr.IJNMR_49_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865247/
https://www.ncbi.nlm.nih.gov/pubmed/35280192
http://dx.doi.org/10.4103/ijnmr.IJNMR_49_20

Ejemplares similares